FDA grants accelerated approval to tazemetostat for follicular lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to tazemetostat, an EZH2 inhibitor, for…
The Food and Drug Administration (FDA) granted accelerated approval to tazemetostat, an EZH2 inhibitor, for…
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
The Food and Drug Administration (FDA) approved nivolumab for patients with unresectable advanced, recurrent or…
On May 19, 2020, the Food and Drug Administration approved olaparib for adult patients with…
The Food and Drug Administration (FDA) granted accelerated approval to selpercatinib for the following indications:…
The Food and Drug Administration (FDA) expanded the indication of olaparib to include its combination…
The Food and Drug Administration (FDA) granted accelerated approval to capmatinib for adult patients with…
The Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj for adult patients with newly…
The Food and Drug Administration (FDA) approved niraparib for the maintenance treatment of adult patients…
The Food and Drug Administration (FDA) approved mitomycin for adult patients with low-grade upper tract…